Mark D Hurwitz

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 117:5579-88. 2011
  2. ncbi Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 53:913-8. 2002
  3. ncbi Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 53:1106-10. 2002
  4. pmc Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts 02115, USA
    Cancer 117:510-6. 2011
  5. doi Today's thermal therapy: not your father's hyperthermia: challenges and opportunities in application of hyperthermia for the 21st century cancer patient
    Mark D Hurwitz
    Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA, USA
    Am J Clin Oncol 33:96-100. 2010
  6. ncbi Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Hyperthermia 21:649-56. 2005
  7. doi Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA 02115, USA
    Nat Clin Pract Oncol 5:668-76. 2008
  8. ncbi Radical prostatectomy for high-grade prostate cancer
    Mark D Hurwitz
    Harvard Medical School, and Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts 02115, USA
    Urology 68:367-70. 2006
  9. doi Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809
    Mark D Hurwitz
    Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 72:814-9. 2008
  10. doi Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate
    Michele Albert
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Urol Oncol 26:147-52. 2008

Detail Information

Publications17

  1. pmc Combination external beam radiation and brachytherapy boost with androgen deprivation for treatment of intermediate-risk prostate cancer: long-term results of CALGB 99809
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Brigham and Women s Hospital, and Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 117:5579-88. 2011
    ....
  2. ncbi Association of rectal toxicity with thermal dose parameters in treatment of locally advanced prostate cancer with radiation and hyperthermia
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 53:913-8. 2002
    ..In this report, we correlate rectal toxicity with thermal dose parameters for patients treated with hyperthermia and radiation for prostate cancer...
  3. ncbi Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 53:1106-10. 2002
    ....
  4. pmc Hyperthermia combined with radiation for the treatment of locally advanced prostate cancer: long-term results from Dana-Farber Cancer Institute study 94-153
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts 02115, USA
    Cancer 117:510-6. 2011
    ..The authors present long-term results from a phase 2 study that assessed the efficacy of transrectal ultrasound hyperthermia plus radiation with or without androgen suppression for the treatment of locally advanced prostate cancer...
  5. doi Today's thermal therapy: not your father's hyperthermia: challenges and opportunities in application of hyperthermia for the 21st century cancer patient
    Mark D Hurwitz
    Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA, USA
    Am J Clin Oncol 33:96-100. 2010
    ..The progress made in understanding of thermal biology, physics, and bioengineering, coupled with advances in complementary clinical treatment modalities have all contributed to the next generation of clinical thermal therapy...
  6. ncbi Hyperthermia combined with radiation in treatment of locally advanced prostate cancer is associated with a favourable toxicity profile
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Hyperthermia 21:649-56. 2005
    ..In this report, short- and long-term toxicity profiles of a completed phase II trial of transrectal ultrasound hyperthermia combined with radiation in treatment of locally advanced prostate cancer are presented...
  7. doi Technology Insight: Combined external-beam radiation therapy and brachytherapy in the management of prostate cancer
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA 02115, USA
    Nat Clin Pract Oncol 5:668-76. 2008
    ....
  8. ncbi Radical prostatectomy for high-grade prostate cancer
    Mark D Hurwitz
    Harvard Medical School, and Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts 02115, USA
    Urology 68:367-70. 2006
    ..The objective of this study was to assess whether use of other known prognostic factors could be helpful in defining which men with Gleason 8 to 10 prostate cancer are most likely to benefit from surgical management...
  9. doi Combination external beam radiation and brachytherapy boost with androgen suppression for treatment of intermediate-risk prostate cancer: an initial report of CALGB 99809
    Mark D Hurwitz
    Dana Farber Brigham and Women s Cancer Center, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 72:814-9. 2008
    ..The results of a multicenter Phase II trial assessing safety of combination of EBRT and TPPB boost with androgen suppression (AST) in treatment of intermediate-risk prostate cancer are present here...
  10. doi Defining the rectal dose constraint for permanent radioactive seed implantation of the prostate
    Michele Albert
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Urol Oncol 26:147-52. 2008
    ..This study was performed to define the rectal dose constraint that would predict late rectal bleeding requiring argon plasma coagulation (APC) following prostate brachy mono-therapy...
  11. pmc Updated results of magnetic resonance imaging guided partial prostate brachytherapy for favorable risk prostate cancer: implications for focal therapy
    Paul L Nguyen
    Department of Radiation Oncology, Dana Farber Cancer Institute, and Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    J Urol 188:1151-6. 2012
    ..We report updated results of magnetic resonance imaging guided partial prostate brachytherapy and propose a definition of biochemical failure following focal therapy...
  12. doi Low rate of clinician-scored gynecomastia induced by 6 months of combined androgen blockade in a randomized trial: Implications for prophylactic breast irradiation
    Amar U Kishan
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts
    Pract Radiat Oncol 2:172-8. 2012
    ..To determine the incidence and predictors of clinician-scored gynecomastia induced by 6 months of combined androgen blockade (CAB) in a randomized trial...
  13. ncbi Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer
    Clair Beard
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 66:403-7. 2006
    ..To identify an association between perineural invasion (PNI) and cancer-specific survival in patients with prostate cancer after standard-dose external beam radiation therapy (RT)...
  14. ncbi Evidence-based review of three-dimensional conformal radiotherapy for localized prostate cancer: an ASTRO outcomes initiative
    David E Morris
    Department of Radiation Oncology, University of North Carolina, Chapel Hill, NC 27514, USA
    Int J Radiat Oncol Biol Phys 62:3-19. 2005
    ....
  15. ncbi Late genitourinary and gastrointestinal toxicity after magnetic resonance image-guided prostate brachytherapy with or without neoadjuvant external beam radiation therapy
    Michele Albert
    Department of Radiation Oncology, Brigham and Women s Hospital, 75 Francis Street, L 2 Level, Boston, MA 02115, USA
    Cancer 98:949-54. 2003
    ..This study was designed to estimate the rates of late genitourinary (GU) and rectal toxicity after magnetic resonance image (MRI)-guided prostate brachytherapy exclusively or in conjunction with external beam radiation therapy (EBRT)...
  16. pmc Radiation therapy induces circulating serum Hsp72 in patients with prostate cancer
    Mark D Hurwitz
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center and Harvard Medical School, Boston, MA, USA
    Radiother Oncol 95:350-8. 2010
    ..Hsp72 found in the extracellular milieu has been shown to play an important role in immune regulation. The impact of common cancer therapies on extracellular release of Hsp72 however, has been to date undefined...
  17. ncbi In regard to Vasanathan et al. (Int J Radiat Oncol Biol Phys 2005;61:145-153)
    Ellen L Jones
    Int J Radiat Oncol Biol Phys 63:644. 2005